<DOC>
	<DOCNO>NCT01981655</DOCNO>
	<brief_summary>The objective trial see whether : -Cardiac performance ( cardiac index secondary outcome ) improve patient acute heart failure ( AHF ) symptom consequence fluid overload ( pulmonary interstitial edema ) poor peripheral perfusion reduce : 1 . Providing lactate substrate ( Improve cardiac index ) 2 . Simultaneously restore optimal preload Optimal standard treatment achieve arm use current best treatment protocol AHF per independent treat physician . 4 . To assess effect 0.5M Na lactate ( Totilac ) plasma urine biological parameter ( sodium , potassium , chloride , pH , bicarb , base excess , albumin ) 5 . To assess effect 0.5M Na lactate morbidity mortality .</brief_summary>
	<brief_title>0.5M Na Lactate Solution Acute Heart Failure ( AHF )</brief_title>
	<detailed_description>- Acute heart failure critical illness current treatment suboptimal . - The various symptom related inadequate cardiac output usually include left ventricular overload pulmonary oedema , interstitial fluid accumulation tissue oedema ( indicated frequent hyponatremia hypoalbuminemia ) insufficient peripheral perfusion frequently manifest cold extremity low urine output . - The current treatment syndrome base diuretic , vasodilator and/or inotropes , fluid administration also require optimise intravascular volume state reverse shock present . Therefore management body fluid balance remain challenge since treatment aim simultaneously maintain improve intravascular volume decrease body fluid excess oedema . - The purpose present study assess prospective randomise trial efficacy safety newly design crystalloid solution , 0.5 M sodium lactate , property potentially able improve multiple pathophysiological aspect AHF , compare use standard crystalloid solution Compound Sodium Lactate ( mildly hypoosmolar ~ 274 mOsm/L isotonic ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Age : 18 year Heart failure criterion : Left heart failure : evidence 2 3 : Left ventricular ejection fraction ( LVEF ) ≤ 40 % cardiac index ≤ 2.5 L/min/m2 Acute pulmonary oedema cardiac origin mechanical ventilation ( include CPAP/BIPAP ) respiratory failure predominantly cardiac origin Need inotropes/vasopressors cardiac pump failure OR Right heart failure : evidence 1 2 : Bilateral leg oedema ankle RV failure ( low tricuspid annular plane systolic excursion ( TAPSE ) , dilate floppy RV ) Poor peripheral perfusion evidence 2 3 : Cold mottle skin Low urine output Acutely cloud sensorium/poor mentation Consent obtain patient patient 's next kin . Hypernatremia : [ Na ] &gt; 145 mmol/L Diagnosed hypertrophic obstructive cardiomyopathy Uncorrected severe valvular heart disease Documented third degree heart block , sustain ventricular tachycardia Documented cardiac tamponade Septic shock Acute respiratory distress syndrome ( ARDS ) Moribund patient likely die 24h Patients major disease limit prognosis end stage cancer , endstage liver failure , end stage dialysis dependent renal failure Patients absolute indication acute hemodialysis/hemofiltration ( pH , K , urea &gt; 35 mmol/L , severe fluid overload presence oliguria &lt; 200 mL/6h . Known pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Sodium Lactate</keyword>
	<keyword>Acute</keyword>
	<keyword>Heart</keyword>
	<keyword>Failure</keyword>
	<keyword>Perfusion</keyword>
</DOC>